Common Name(s): Baptitoxine, Sophorine
Medically reviewed by Drugs.com. Last updated on Mar 1, 2018.
Limited clinical data support a place in therapy for cytisine use in smoking cessation.
Limited clinical studies are available to guide dosage. In studies of smoking cessation, the suggested dosing regimen was one cytisine dose (tablet or capsule: 1.5 mg; oral strip: 1 mg) every 2 hours initially (6 doses per day), then titrated downward over 25 days to 2 doses per day.
Contraindications for use include pregnancy and breastfeeding, advanced atherosclerosis, and uncontrolled hypertension.
Avoid use. Information regarding use in pregnancy and lactation is lacking.
Information is limited. Data are lacking regarding use with other smoking cessation agents; concurrent use should be avoided.
GI disorders (dyspepsia and nausea), headache, increased appetite, dry mouth, nightmares, and irritability have been reported.
Cytisine toxicity is considered to be dose dependent, and reports of fatalities due to respiratory failure following consumption of L. anagyroides plant material exist.
- Fabaceae (pea)
Cytisine is an alkaloid that exists naturally in the seeds of plants belonging to the Leguminosae/Fabaceae family, particularly L. anagyroides.Rouden 2014, Stead 2007 L. anagyroides, a small decorative garden tree (also called the Golden Rain Acacia due to its golden yellow flowers), is common in Central and Southern Europe. A synonym for L. anagyroides is Cytisus laburnum.USDA 2018, Rouden 2014
The plant species Ulex europaeus L., Baptisia tinctoria, and Sophora secundiflora contain chemicals previously identified as unique compounds (ulexine, sophorine, baptitoxine) but later determined to be identical to cytisine.Rouden 2014
Traditional use of Laburnum seeds for their emetic effects, and use of the leaves of L. anagyroides as a tobacco substitute have been documented. By the late 19th century, the chemical structure and synthesis of cytisine was developed. Cytisine has been marketed for use in treatment of tobacco dependence in Central and Eastern Europe since the 1960s. Since the 1990s, a resurgence in interest in cytisine chemistry and potential therapeutic applications has resulted in a rise in the number of published studies evaluating its use; however, clinical trial data are lacking. Products containing cytisine are available in Russia and Poland, in other former Soviet countries, in Canada, and via the internet.Aveyard 2013, Gross 2015, Hajek 2013, Prochaska 2016, Rouden 2014
Methods of cytisine extraction from the seeds of L. anagyroides have been elucidated. Cytisine is a partial nicotinic agonist, similar to the FDA-approved drug varenicline.Astroug 2010, Aveyard 2013, Jeong 2015, Jeong 2017, Rouden 2014
Uses and Pharmacology
Appetite suppressant effects
A study in rats reported that cytisine-treated animals ate less and gained less weight than the control arm.Grebenstein 2013
Clinical trials evaluating the effect of cytisine on appetite are lacking; however, subjects in an open-label pharmacokinetic study in healthy adults conversely reported increased appetite.Jeong 2017
In vitro data
Cytisine induced apoptosis in HepG2 cells via a mitochondrial pathway, suggesting potential chemotherapeutic applications.Yu 2018
Animal and in vitro data
In vitro studies suggest neuronal protective effects of cytisine through mechanisms that involve downregulation of N-methyl-D-aspartate (NMDA) receptors.Li 2013 Limited studies in rodents have reported efficacy in treating induced depression. Treatment with cytisine for 2 weeks relieved symptoms related to unpredictable chronic mild stress.Han 2016 In another study of a mouse model, fluoxetine and cytisine were shown to have synergistic effects on depression, whereas serotonin depletion blocked the antidepressant effects of cytisine.Mineur 2015 A study in rats suggested cytisine attenuated the mental discomfort associated with nicotine withdrawal.Igari 2014 A study in rodents showed cytisine modulates chronic voluntary ethanol consumption, suggesting a possible role in alcohol addiction.Sajja 2013, Sotomajor 2013
A study in mice reported efficacy in treatment of type 2 diabetes with a combination preparation containing cytisine with a water-soluble analog of vitamin E (Trolox C).Jin 2014
Cytisine as an option in smoking cessation has been the topic of a number of supportive journal articles and editorials.Mulhall 2015, Prochaska 2016, Rigotti 2014, Stapleton 2015, Walker 2016, Zatonski 2015
Studies in rodents suggest cytisine is a nicotinic receptor agonist, behaving as both a competitive partial agonist and full agonist, depending on the subunit of attachment. Cytisine appears to have weaker peripheral effects on the cardiovascular system than nicotine.Radchenko 2015, Rouden 2014
Meta-analyses of available clinical trial data have been conducted, with 2 quality clinical studies identifiedVinnikov 2008, West 2011 and up to 9 other clinical studies evaluated.Cahil 2013, Hajek 2013, Leaviss 2014, Samet 2014 No head-to-head trials comparing varenicline with cytisine had been conducted as of January 2013; however, further trials evaluating cytisine have been registered or are in progress.Leaviss 2014, NIH 2018
One quality clinical trial evaluating cytisine versus placebo in middle-age smokers reported no difference in abstinence at 8 weeks, but a significant difference in abstinence at 26 weeks (10.6% for the cytisine group compared to 1.2% with placebo [P=0.01]).Vinnikov 2008 A second quality clinical trial enrolled 740 participants in a single-center, randomized, double-blind, placebo-controlled trial and reported a sustained 12-month abstinence rate of 8.4% in the cytisine group compared with 2.4% in the placebo group (95% confidence interval [CI], 2.7% to 9.2%; P=0.001).West 2011 Pooled results from these 2 clinical trials show a risk ratio for successful cessation of 3.29 (95% CI, 1.84 to 5.9) with cytisine intervention.Hajek 2013, Samet 2014
Another open-label, noninferiority trial randomly assigned 1,310 adult daily smokers to oral cytisine for 25 days or nicotine replacement therapy for 8 weeks. Cytisine was superior to nicotine replacement therapy, with higher continuous abstinence rates at 1 week, 2 months, and 6 months.Walker 2014 This study was noted to have certain methodological limitations.Mulhall 2015
Cytisine is available as tablets and capsules (both containing cytisine 1.5 mg), and as oral strips (cytisine 1 mg).Jeong 2017 All 3 doseforms are associated with the same recommended dosing regimen for smoking cessation: One dose every 2 hours (6 doses per day) for days 1 through 3, with the dosing interval increased to every 2.5 hours (5 doses per day) days 4 through 12, to every 4 hours (4 doses per day) days 13 through 16, to every 5 hours (3 doses per day) days 17 through 20, and to every 6 hours (2 doses per day) days 21 through 25. The recommended target "quit day" is day 5.Jeong 2017, West 2011
Pharmacokinetic studies conducted in rabbitsAstroug 2010 and healthy human volunteersJeong 2017 reported rapid but incomplete absorption following oral administration. The half-life is estimated to be about 5 hours.Jeong 2017 A pharmacokinetic study reported cytisine is renally excreted, with no metabolites detected in plasma or urine.Jeong 2015
Pregnancy / Lactation
Information regarding use in pregnancy or lactation is lacking. At 4 to 5 weeks' gestation, nicotinic receptor proteins and gene transcripts for nicotinic receptor subunits exist in the human prenatal brain, making the consequences of cytisine use during pregnancy potentially similar to that of smoking.Hellstrom 2001
Theoretically, an interaction with varenicline, also used in smoking cessation, is possible, given that both act at the nicotinic receptor.
Evidence supports the safety of cytisine; long periods of postmarketing surveillance exist in the European Medicines Authority database.Aveyard 2013, Hajek 2013 However, dose-dependent reports of toxicity exist (see Toxicology).
In an open-label pharmacokinetic study in healthy adults, no effects on blood pressure or respiratory rate were observed, and reported adverse effects included increased appetite, dry mouth, dream/nightmares, and irritability.Jeong 2017 Similar findings have been reported in a systematic review of the literature.Leaviss 2014
A Cochrane meta-analysis of 3 clinical trials using cytisine report a lack of significant adverse effects, with GI disorders (dyspepsia and nausea) and headache most commonly reported.Cahill 2013 Similarly, a review that included 8 clinical trials reported more adverse GI effects with cytisine than placebo (relative risk, 1.76; 95% CI, 1.28 to 2.42) but no significant safety concerns.Hajek 2013
Contraindications for use include pregnancy and breastfeeding, severe atherosclerosis, and uncontrolled hypertension.Prochaska 2013
Animal studies have shown that the leaves and seeds of L. anagyroides and related plants are toxic. A lethal dose in horses has been estimated to be 0.5 g/kg of L. anagyroides seedpods.Jeong 2017, Rouden 2014, Simeonova 2010
No antidote to cytisine toxicity has been identified, and management is supportive.Rouden 2014
- Laburnum anagyroides
- Golden chain acacia
- Golden rain acacia
- Kowhai (New Zealand)
This information relates to an herbal, vitamin, mineral or other dietary supplement. This product has not been reviewed by the FDA to determine whether it is safe or effective and is not subject to the quality standards and safety information collection standards that are applicable to most prescription drugs. This information should not be used to decide whether or not to take this product. This information does not endorse this product as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this product. It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from your health care provider. You should talk with your health care provider for complete information about the risks and benefits of using this product.
This product may adversely interact with certain health and medical conditions, other prescription and over-the-counter drugs, foods, or other dietary supplements. This product may be unsafe when used before surgery or other medical procedures. It is important to fully inform your doctor about the herbal, vitamins, mineral or any other supplements you are taking before any kind of surgery or medical procedure. With the exception of certain products that are generally recognized as safe in normal quantities, including use of folic acid and prenatal vitamins during pregnancy, this product has not been sufficiently studied to determine whether it is safe to use during pregnancy or nursing or by persons younger than 2 years of age.
Copyright © 2019 Wolters Kluwer Health